LISATA THERAPEUTICS, INC. — Director's Dealing 2016

May 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2016-04-25

Reporting Person: LOSORDO DOUGLAS W (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-25	Common Stock	F	1714	$0.68	Disposed	125121	Direct

Footnotes

F1: Includes 52,250 shares of unvested restricted stock.